Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 40,000 shares of Avidity Biosciences stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $35.07, for a total transaction of $1,402,800.00. Following the completion of the transaction, the director now directly owns […]
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) Director William D. Waddill sold 8,000 shares of the firm’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $35.00, for a total transaction of $280,000.00. Following the completion of the transaction, the director now directly owns 12,000 shares […]
PIMCO California Municipal Income Fund III (NYSE:PZC – Get Free Report)’s share price passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $7.34 and traded as low as $6.99. PIMCO California Municipal Income Fund III shares last traded at $7.02, with […]
Shares of PennantPark Investment Co. (NASDAQ:PNNT – Get Free Report) hit a new 52-week high during trading on Wednesday . The company traded as high as $7.69 and last traded at $7.67, with a volume of 614787 shares traded. The stock had previously closed at $7.51. Wall Street Analyst Weigh In Several equities research analysts […]
Simmons First National (NASDAQ:SFNC – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Monday. SFNC has been the topic of a number of other reports. Stephens cut their price target on shares of Simmons First National from $22.00 to […]